• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越初次通过:血管再通在卒中取栓中仍然至关重要。

Beyond the first pass: revascularization remains critical in stroke thrombectomy.

机构信息

Division of Interventional Neuroradiology, University of Maryland Medical Center, Baltimore, Maryland, USA.

Department of Neurosurgery, University of Maryland Medical Center, Baltimore, Maryland, USA.

出版信息

J Neurointerv Surg. 2019 Nov;11(11):1095-1099. doi: 10.1136/neurintsurg-2019-014773. Epub 2019 May 2.

DOI:10.1136/neurintsurg-2019-014773
PMID:31048458
Abstract

BACKGROUND

The first pass effect has been recently reported as a predictor of good clinical outcome after stroke thrombectomy. We evaluate the first pass effect on outcome and the influence of revascularization in these and other patients.

METHODS

We performed a retrospective analysis of a prospectively maintained database on anterior cerebral circulation stroke thrombectomy cases from April 2012 to April 2018. Data compiled included patient demographics, presenting National Institutes of Health Stroke Scale score, vessel occlusion site, thrombectomy procedural details, and 90 day modified Rankin Scale scores.

RESULTS

205 patients were included. The numbers of patients who underwent one, two, three, four, five, and six passes were 69, 70, 55, 9, 1, and 1, respectively. Successful revascularization was achieved in 87%, 83%, and 64% of patients in the one, two, and 3 or more passes groups, respectively (p=0.002). Good functional outcome was inversely correlated with number of passes when comparing the one, two, and three or more passes groups (54%, 43%, 29%; P=0.014). In patients with full revascularization, there was no significant difference in good functional outcomes between the one, two, and three or more passes groups (64%, 65%, 50%; P=0.432). Number of passes was not an independent negative predictor of good clinical outcome (OR 1.66, 95% CI 0.82 to 3.39; P=0.165).

CONCLUSIONS

First pass thrombectomy patients have better functional outcomes compared with beyond-first pass patients. This effect is related at least in part to a higher rate of revascularization in one pass patients. Revascularization beyond the first pass should continue to be the goal of stroke thrombectomy.

摘要

背景

首次通过效应最近被报道为卒中取栓后良好临床结局的预测因素。我们评估了首次通过效应对结局的影响,以及在这些患者和其他患者中血管再通的影响。

方法

我们对 2012 年 4 月至 2018 年 4 月期间前循环卒中取栓病例的前瞻性维护数据库进行了回顾性分析。收集的数据包括患者人口统计学资料、就诊时美国国立卫生研究院卒中量表评分、血管闭塞部位、取栓术细节和 90 天改良 Rankin 量表评分。

结果

共纳入 205 例患者。行 1 次、2 次、3 次、4 次、5 次和 6 次取栓的患者分别为 69、70、55、9、1 和 1 例。1 次、2 次和 3 次或更多次取栓组的血管再通成功率分别为 87%、83%和 64%(p=0.002)。比较 1 次、2 次和 3 次或更多次取栓组,良好的功能结局与取栓次数呈负相关(54%、43%、29%;P=0.014)。在完全血管再通的患者中,1 次、2 次和 3 次或更多次取栓组的良好功能结局无显著差异(64%、65%、50%;P=0.432)。取栓次数不是良好临床结局的独立负预测因素(OR 1.66,95%CI 0.82 至 3.39;P=0.165)。

结论

首次通过取栓患者的功能结局优于超过首次通过取栓患者。这种效应至少部分与首次通过取栓患者的血管再通率较高有关。血管再通应继续作为卒中取栓的目标。

相似文献

1
Beyond the first pass: revascularization remains critical in stroke thrombectomy.超越初次通过:血管再通在卒中取栓中仍然至关重要。
J Neurointerv Surg. 2019 Nov;11(11):1095-1099. doi: 10.1136/neurintsurg-2019-014773. Epub 2019 May 2.
2
Successful reperfusion, rather than number of passes, predicts clinical outcome after mechanical thrombectomy.成功再灌注而非灌注次数可预测机械取栓术后的临床结局。
J Neurointerv Surg. 2020 Jun;12(6):548-551. doi: 10.1136/neurintsurg-2019-015330. Epub 2019 Nov 1.
3
When to Stop.何时停止。
Stroke. 2019 Jul;50(7):1781-1788. doi: 10.1161/STROKEAHA.119.025088. Epub 2019 Jun 10.
4
Effects of first pass recanalization on outcomes of contact aspiration thrombectomy.直接再通对接触抽吸血栓切除术结局的影响。
J Neurointerv Surg. 2020 May;12(5):466-470. doi: 10.1136/neurintsurg-2019-015221. Epub 2019 Sep 28.
5
Frontline ADAPT therapy to treat patients with symptomatic M2 and M3 occlusions in acute ischemic stroke: initial experience with the Penumbra ACE and 3MAX reperfusion system.采用前线 ADAPT 疗法治疗急性缺血性脑卒中症状性 M2 和 M3 闭塞患者:Penumbra ACE 和 3MAX 再灌注系统的初步经验。
J Neurointerv Surg. 2018 May;10(5):434-439. doi: 10.1136/neurintsurg-2017-013233. Epub 2017 Aug 18.
6
Mechanical Thrombectomy in Distal Vessels: Revascularization Rates, Complications, and Functional Outcome.机械血栓切除术治疗远端血管病变:再通率、并发症和功能结局。
World Neurosurg. 2019 Oct;130:e1098-e1104. doi: 10.1016/j.wneu.2019.07.098. Epub 2019 Jul 16.
7
True first-pass effect in basilar artery occlusions: First-pass complete reperfusion improves clinical outcome in stroke thrombectomy patients.基底动脉闭塞的真正首次通过效应:首次通过完全再灌注可改善血管内取栓治疗的卒中患者的临床转归。
J Clin Neurosci. 2021 Jul;89:33-38. doi: 10.1016/j.jocn.2021.04.020. Epub 2021 Apr 29.
8
Long term experience using the ADAPT technique for the treatment of acute ischemic stroke.ADAPT 技术治疗急性缺血性脑卒中的长期经验。
J Neurointerv Surg. 2017 May;9(5):437-441. doi: 10.1136/neurintsurg-2015-012211. Epub 2016 Apr 18.
9
Number of stentriever passes and outcome after thrombectomy in stroke.取栓支架通过次数与卒中取栓术后结局
J Neuroradiol. 2019 Sep;46(5):327-330. doi: 10.1016/j.neurad.2019.03.014. Epub 2019 Apr 11.
10
Impact of Balloon Guide Catheter Use on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry.在 STRATIS 卒中取栓登记研究中,球囊导引导管使用对临床和血管造影结局的影响。
Stroke. 2019 Mar;50(3):697-704. doi: 10.1161/STROKEAHA.118.021126.

引用本文的文献

1
Number of Retrieval Attempts and the Association of Intravenous Tirofiban with Symptomatic Intracranial Hemorrhage in Patients with Successful Endovascular Therapy: Results of the RESCUE BT Trial.血管内治疗成功的患者中替罗非班静脉注射次数与症状性颅内出血的关联:RESCUE BT试验结果
Clin Interv Aging. 2024 Nov 29;19:2001-2012. doi: 10.2147/CIA.S481084. eCollection 2024.
2
Trevo 3 Mm and/or AXS Catalyst 5 for the Treatment of Medium Distal Vessel Occlusion Stroke-results from the ASSIST Registry.用于治疗中远端血管闭塞性卒中的Trevo 3毫米和/或AXS Catalyst 5——ASSIST注册研究结果
Clin Neuroradiol. 2025 Mar;35(1):51-57. doi: 10.1007/s00062-024-01450-y. Epub 2024 Aug 23.
3
SOFIA Aspiration System as first-line Technique (SOFAST): a prospective, multicenter study to assess the efficacy and safety of the 6 French SOFIA Flow Plus aspiration catheter for endovascular stroke thrombectomy.
SOFIA抽吸系统作为一线技术(SOFAST):一项前瞻性、多中心研究,旨在评估6F SOFIA Flow Plus抽吸导管用于血管内卒中血栓切除术的有效性和安全性。
J Neurointerv Surg. 2025 Jun 16;17(7):753-758. doi: 10.1136/jnis-2024-021811.
4
Technique and impact on first pass effect primary results of the ASSIST global registry.ASSIST全球注册研究的技术及对首过效应的主要影响结果
J Neurointerv Surg. 2025 Jan 17;17(2):128-138. doi: 10.1136/jnis-2023-021126.
5
Clinical Benefit of First-Pass Recanalization Is Time-Dependent in Endovascular Treatment of Acute Ischemic Stroke.首次通过再通在急性缺血性卒中血管内治疗中的临床益处具有时间依赖性。
J Clin Med. 2023 Oct 18;12(20):6596. doi: 10.3390/jcm12206596.
6
Evaluation of effectiveness and safety of the multizone NeVa stent retriever for mechanical thrombectomy in ischemic stroke.多区域 NeVa 支架取栓器在缺血性脑卒中机械取栓中的有效性和安全性评估。
Neuroradiology. 2023 Dec;65(12):1777-1785. doi: 10.1007/s00234-023-03236-4. Epub 2023 Oct 25.
7
Impact on Endovascular Thrombectomy for Acute Ischemic Stroke of Aortic Arch Calcification on Chest X-ray.胸部X线片上主动脉弓钙化对急性缺血性卒中血管内血栓切除术的影响
J Clin Med. 2023 Sep 22;12(19):6115. doi: 10.3390/jcm12196115.
8
Bridging therapy improves functional outcomes and reduces 90-day mortality compared with direct endovascular thrombectomy in patients with acute posterior ischemic stroke: a systematic review and meta-analysis.桥接治疗可改善急性后循环缺血性卒中患者的功能结局,降低 90 天死亡率:一项系统评价和荟萃分析。
Neurol Sci. 2024 Feb;45(2):495-506. doi: 10.1007/s10072-023-07096-x. Epub 2023 Oct 4.
9
Clinical Impact of Large Vessel Occlusion Achieved First Pass Effect with Stent Retriever Alone: A Single-Center Retrospective Analysis.单纯使用支架取栓器实现大血管闭塞首次通过效应的临床影响:单中心回顾性分析
J Neuroendovasc Ther. 2022;16(6):287-293. doi: 10.5797/jnet.oa.2021-0063. Epub 2021 Sep 30.
10
Granulocytes-Rich Thrombi in Cerebral Large Vessel Occlusion Are Associated with Increased Stiffness and Poorer Revascularization Outcomes.富含粒细胞的大脑大血管闭塞血栓与硬度增加和再血管化预后不良相关。
Neurotherapeutics. 2023 Jul;20(4):1167-1176. doi: 10.1007/s13311-023-01385-1. Epub 2023 May 22.